Compare EDD & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EDD | NRC |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 345.5M | 278.8M |
| IPO Year | N/A | N/A |
| Metric | EDD | NRC |
|---|---|---|
| Price | $5.55 | $18.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 254.3K | 89.4K |
| Earning Date | 01-01-0001 | 01-26-2026 |
| Dividend Yield | ★ 7.52% | 3.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | N/A | ★ $139,102,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.22 | $9.76 |
| 52 Week High | $4.95 | $19.39 |
| Indicator | EDD | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 65.79 |
| Support Level | $5.47 | $18.50 |
| Resistance Level | $5.55 | $19.20 |
| Average True Range (ATR) | 0.07 | 0.73 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 26.09 | 83.81 |
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.